- 全部删除
- 您的购物车当前为空
Neihulizumab (ALTB-168) 是一种免疫检查点激动抗体,特异性结合人CD162。该结合作用导致活化T细胞的下调与凋亡,Neihulizumab 可用于研究类固醇难治性急性移植物抗宿主病(GVHD)、银屑病、银屑病关节炎和溃疡性结肠炎。
为众多的药物研发团队赋能,
让新药发现更简单!
Neihulizumab (ALTB-168) 是一种免疫检查点激动抗体,特异性结合人CD162。该结合作用导致活化T细胞的下调与凋亡,Neihulizumab 可用于研究类固醇难治性急性移植物抗宿主病(GVHD)、银屑病、银屑病关节炎和溃疡性结肠炎。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,480 | In stock | |
5 mg | ¥ 7,460 | In stock | |
10 mg | ¥ 9,860 | In stock | |
25 mg | ¥ 14,900 | In stock | |
50 mg | ¥ 19,700 | In stock |
产品描述 | Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that specifically binds to human CD162 (PSGL-1). this binding leads to the downregulation and apoptosis of activated T cells, a mechanism currently in clinical development for the treatment of steroid-refractory acute graft-versus-host disease (GVHD), psoriasis, psoriatic arthritis, and ulcerative colitis. |
别名 | Anti-PSGL1/CD162 Reference Antibody, ALTB-168 |
CAS No. | 2158362-38-8 |
颜色 | Transparent |
物理性状 | Liquid |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容